XML 51 R30.htm IDEA: XBRL DOCUMENT
v3.20.4

Stock-Based Awards | 12 Months Ended
--- | ---
Dec. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock-Based Awards | 21. Stock-Based Awards On June 20, 2016, the Company’s stockholders approved a new equity award plan under which the Company can issue up to 10,000,000 shares of common stock (less one share for every share granted under prior plans since March 31, 2016 and inclusive of shares available under the prior plans as of March 31, 2016) in the form of stock options and other stock-based awards. The Company grants equity awards to employees and directors which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions.
Stock options: |  | Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.
RSAs/RSUs: |  | Awards are valued based on the Company’s stock price on grant date and generally vest ratably over three years.
PRSUs: |  | These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.
|  | The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:
|  | •  If the relative TSR is below the 25 th percentile, then 0% of the target number of PRSUs granted will vest;
|  | •  If the relative TSR is at the 25 th percentile, then 50% of the target number of PRSUs granted will vest; and
|  | •  If the relative TSR is above the 25 th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50 th percentile and capped at 200% of the target number of PRSUs granted for performance at the 100 th percentile.
During the years ended December 31, 2020, 2019 and 2018, total stock-based compensation expense was $11,706, $11,590 and $13,255, respectively, and the related tax benefit recognized on the Consolidated Statements of Operations was $2,739, $2,791 and $3,015, respectively. The actual tax benefit realized for the tax deductions for share-based compensation was $833, $1,649 and $2,364 during the years ended December 31, 2020, 2019 and 2018, respectively. A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:
|  | December 31, 2020 |
|  | Unrecognized Stock- Based Compensation |  |  | Weighted-Average Remaining Vesting Period (Years) |
Employees and directors |  | $ | 9,776 |  |  |  | 1.28 |
Stock Options A summary of option activity is as follows:
|  | Options |  |  | Weighted-Average Exercise Price |
Outstanding January 1, 2018 |  |  | 1,158,828 |  |  | $ | 2.75 |
Granted |  |  | — |  |  |  | — |
Forfeitures/expirations |  |  | — |  |  |  | — |
Exercised |  |  | (588,291 | ) |  |  | 1.19 |
Outstanding at December 31, 2018 |  |  | 570,537 |  |  | $ | 4.36 |
Granted |  |  | — |  |  |  | — |
Forfeitures/expirations |  |  | (1 | ) |  |  | 6.50 |
Exercised |  |  | (85,000 | ) |  |  | 0.70 |
|  | Options |  |  | Weighted-Average Exercise Price |
Outstanding at December 31, 2019 |  |  | 485,536 |  |  | $ | 4.80 |
Granted |  |  | — |  |  |  | — |
Forfeitures/expirations |  |  | (63,536 | ) |  |  | 2.49 |
Exercised |  |  | (117,000 | ) |  |  | 4.81 |
Outstanding at December 31, 2020 (1) |  |  | 305,000 |  |  | $ | 5.68 |
(1) | Expire on dates ranging from January 26, 2021 to November 15, 2021.
The total intrinsic value of options exercised during the years ended December 31, 2020, 2019 and 2018 was $168, $301 and $4,218, respectively. Cash received from option exercises during the years ended December 31, 2020, 2019 and 2018 was $292, $160 and $191, respectively. The following table summarizes information on stock options outstanding and exercisable at December 31, 2020:
|  | Options Outstanding and Exercisable |
Range of Exercise Prices |  | Shares |  |  | Weighted- Average Remaining Life (Years) |  |  | Weighted- Average Exercise Price |
$5.05 |  |  | 190,000 |  |  |  | 0.1 |  |  | $ | 5.05 |
$6.42 – $6.82 |  |  | 67,500 |  |  |  | 0.4 |  |  |  | 6.47 |
$7.01 – $7.30 |  |  | 47,500 |  |  |  | 0.8 |  |  |  | 7.07 |
|  |  | 305,000 |  |  |  | 0.3 |  |  | $ | 5.68 |
At December 31, 20 2 0, outstanding options for 305,000 shares (all of which were exercisable) had a remaining weighted-average contractual term of 0.3 years and an intrinsic value of $57. RSAs, RSUs and PRSUs The aggregate fair value of RSAs, RSUs and PRSUs that vested during the years ended December 31, 2020, 2019 and 2018 was $4,783, $6,720 and $5,975, respectively.A summary of activity is as follows:
|  | RSAs |  |  | RSUs |  |  | PRSUs (1) |
|  | Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Shares |  |  | Weighted Average Grant Date Fair Value |
Unvested Balance at January 1, 2018 |  |  | 1,816,666 |  |  | $ | 11.75 |  |  |  | 5,678 |  |  | $ | 10.40 |  |  |  | — |  |  | $ | — |
Granted |  |  | 903,231 |  |  |  | 11.77 |  |  |  | 7,152 |  |  |  | 12.21 |  |  |  | — |  |  |  | — |
Vested |  |  | (618,516 | ) |  |  | 12.67 |  |  |  | (1,890 | ) |  |  | 10.40 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (144,279 | ) |  |  | 11.83 |  |  |  | (1,446 | ) |  |  | 11.97 |  |  |  | — |  |  |  | — |
Unvested Balance at December 31, 2018 |  |  | 1,957,102 |  |  | $ | 11.47 |  |  |  | 9,494 |  |  | $ | 11.52 |  |  |  | — |  |  | $ | — |
Granted |  |  | 2,794,703 |  |  |  | 6.16 |  |  |  | 35,283 |  |  |  | 6.45 |  |  |  | 270,872 | (2) |  |  | 6.24 |
Vested |  |  | (1,053,980 | ) |  |  | 11.25 |  |  |  | (5,499 | ) |  |  | 9.85 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (453,267 | ) |  |  | 9.09 |  |  |  | — |  |  |  | — |  |  |  | (38,262 | ) |  |  | 6.24 |
Unvested Balance at December 31, 2019 |  |  | 3,244,558 |  |  | $ | 7.29 |  |  |  | 39,278 |  |  | $ | 7.20 |  |  |  | 232,610 |  |  | $ | 6.24 |
Granted |  |  | 1,653,186 |  |  |  | 3.80 |  |  |  | 32,901 |  |  |  | 3.82 |  |  |  | 117,013 | (2) |  |  | 3.11 |
Vested |  |  | (1,206,879 | ) |  |  | 8.13 |  |  |  | (27,130 | ) |  |  | 7.45 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (110,122 | ) |  |  | 4.79 |  |  |  | (5,641 | ) |  |  | 5.39 |  |  |  | (8,311 | ) |  |  | 6.24 |
Unvested Balance at December 31, 2020 |  |  | 3,580,743 |  |  | $ | 5.38 |  |  |  | 39,408 |  |  | $ | 4.46 |  |  |  | 341,312 |  |  | $ | 5.17 |
(1) | Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount.
(2) | A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90-day average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:
|  | Granted in 2020 |  |  | Granted in 2019 |
Historical stock price volatility (low) |  |  | 21 | % |  |  | 22 | %
Historical stock price volatility (high) |  |  | 36 | % |  |  | 42 | %
Historical stock price volatility (average) |  |  | 26 | % |  |  | 28 | %
Risk free interest rate |  |  | 1.47 | % |  |  | 2.56 | %
Expected dividend yield |  |  | 0.0 | % |  |  | 0.0 | %

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration